Literature DB >> 10672118

Racial differences in the utilization of oral anticoagulant therapy in heart failure: a study of elderly hospitalized patients.

S A Ibrahim1, C K Kwoh, D L Harper, D W Baker.   

Abstract

To assess racial differences in the use of oral anticoagulant therapy for patients with heart failure, we conducted a cohort study of 30 hospitals in northeast Ohio. For 12,911 Medicare enrollees consecutively admitted in 1992 through 1994 with heart failure, crude and adjusted odds of being on oral anticoagulation were determined. The crude and adjusted odds of being African Americans on oral anticoagulant therapy relative to whites were 0.57 (95% confidence interval 0.47-0.69) and 0.55 (95% confidence interval 0. 45-0.67), respectively. African-Americans with heart failure were much less likely than whites to receive oral anticoagulant therapy, even after adjusting for other variables associated with anticoagulant use.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10672118      PMCID: PMC1495339          DOI: 10.1046/j.1525-1497.2000.05199.x

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  16 in total

1.  The use of dicumarol as an adjunct to the treatment of congestive heart failure; results in a controlled series of 61 cases.

Authors:  G M ANDERSON; E HULL
Journal:  South Med J       Date:  1948-04       Impact factor: 0.954

2.  Dicumarol prophylaxis of thromboembolic disease in congestive heart failure.

Authors:  W P HARVEY; C A FINCH
Journal:  N Engl J Med       Date:  1950-02-09       Impact factor: 91.245

3.  Failure to prescribe warfarin to patients with nonrheumatic atrial fibrillation.

Authors:  M R Antani; R J Beyth; K E Covinsky; P A Anderson; D G Miller; R D Cebul; L M Quinn; C S Landefeld
Journal:  J Gen Intern Med       Date:  1996-12       Impact factor: 5.128

4.  Declines in hospital mortality associated with a regional initiative to measure hospital performance.

Authors:  G E Rosenthal; L Quinn; D L Harper
Journal:  Am J Med Qual       Date:  1997       Impact factor: 1.852

5.  The effect of race and sex on physicians' recommendations for cardiac catheterization.

Authors:  K A Schulman; J A Berlin; W Harless; J F Kerner; S Sistrunk; B J Gersh; R Dubé; C K Taleghani; J E Burke; S Williams; J M Eisenberg; J J Escarce
Journal:  N Engl J Med       Date:  1999-02-25       Impact factor: 91.245

6.  Physician variation in anticoagulating patients with atrial fibrillation. Dartmouth Primary Care COOP Project.

Authors:  H J Chang; J R Bell; D B Deroo; J W Kirk; J H Wasson
Journal:  Arch Intern Med       Date:  1990-01

7.  Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

Authors: 
Journal:  N Engl J Med       Date:  1987-06-04       Impact factor: 91.245

8.  Physician attitudes about anticoagulation for nonvalvular atrial fibrillation in the elderly.

Authors:  D C McCrory; D B Matchar; G Samsa; L L Sanders; E L Pritchett
Journal:  Arch Intern Med       Date:  1995-02-13

9.  Incidence of thromboembolic events in congestive heart failure. The V-HeFT VA Cooperative Studies Group.

Authors:  W B Dunkman; G R Johnson; P E Carson; G Bhat; L Farrell; J N Cohn
Journal:  Circulation       Date:  1993-06       Impact factor: 29.690

10.  Cleveland health quality choice: a model for collaborative community-based outcomes assessment.

Authors:  G E Rosenthal; D L Harper
Journal:  Jt Comm J Qual Improv       Date:  1994-08
View more
  6 in total

1.  Racial Disparities in Health Service Utilization Among Medicare Fee-for-Service Beneficiaries Adjusting for Multiple Chronic Conditions.

Authors:  Krupa Gandhi; Eunjung Lim; James Davis; John J Chen
Journal:  J Aging Health       Date:  2017-06-16

2.  Racial differences in 30-day mortality for pulmonary embolism.

Authors:  Said A Ibrahim; Roslyn A Stone; D Scott Obrosky; Jennifer Sartorius; Michael J Fine; Drahomir Aujesky
Journal:  Am J Public Health       Date:  2006-10-31       Impact factor: 9.308

3.  Racial and Insurance Status Disparities in Patient Safety Indicators among Hospitalized Patients.

Authors:  Jay J Shen; Christopher R Cochran; Olena Mazurenko; Charles B Moseley; Guogen Shan; Robin Mukalian; Scott Neishi
Journal:  Ethn Dis       Date:  2016-07-21       Impact factor: 1.847

4.  Atrial Fibrillation and Race - A Contemporary Review.

Authors:  Michael K D Amponsah; Emelia J Benjamin; Jared W Magnani
Journal:  Curr Cardiovasc Risk Rep       Date:  2013-10

5.  Racial Differences in Atrial Fibrillation-Related Cardiovascular Disease and Mortality: The Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Jared W Magnani; Faye L Norby; Sunil K Agarwal; Elsayed Z Soliman; Lin Y Chen; Laura R Loehr; Alvaro Alonso
Journal:  JAMA Cardiol       Date:  2016-07-01       Impact factor: 14.676

Review 6.  Use of oral anticoagulants in African-American and Caucasian patients with atrial fibrillation: is there a treatment disparity?

Authors:  Olakunle Akinboboye
Journal:  J Multidiscip Healthc       Date:  2015-05-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.